Archival Report| Volume 65, ISSUE 4, P283-288, February 15, 2009

Download started.


Vaccination as a Novel Approach for Treating Depressive Behavior


      Depressive behavior in animals is often associated with reduced levels of brain-derived neurotrophic factor (BDNF) and impaired neurogenesis in the hippocampus. Recent studies showed that T cells recognizing central nervous system (CNS)-specific antigens can regulate adult hippocampal neurogenesis and expression of BDNF. On the basis of these findings, we hypothesized that controlling CNS specific immune activity by immunization with a myelin-related peptide may have an antidepressant effect.


      We investigated the impact of immunization with a CNS related peptide, on the behavioral and cellular outcomes of chronic mild stress (CMS; an animal model for depression) in rats.


      Immunization with a weak agonist of a myelin-derived peptide ameliorated depressive behavior such as anhedonia (measured by sucrose preference), induced by CMS in rats. The behavioral outcome was accompanied by restoration of hippocampal BDNF levels and neurogenesis.


      The results of this study introduce a novel approach of immunization with CNS-related antigens as a therapeutic means for fighting depression. Vaccination, as an antidepressant therapy, may invoke several molecular and cellular pathways that are known to be regulated by antidepressant drugs. Therefore, we suggest that immune-based therapies should be considered for treatment of depression.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kessler R.C.
        • Berglund P.
        • Demler O.
        • Jin R.
        • Koretz D.
        • Merikangas K.R.
        • et al.
        The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R).
        JAMA. 2003; 289: 3095-3105
        • Duman R.S.
        Depression: A case of neuronal life and death?.
        Biol Psychiatry. 2004; 56: 140-145
        • Duman R.S.
        • Monteggia L.M.
        A neurotrophic model for stress-related mood disorders.
        Biol Psychiatry. 2006; 59: 1116-1127
        • Gronli J.
        • Bramham C.
        • Murison R.
        • Kanhema T.
        • Fiske E.
        • Bjorvatn B.
        • et al.
        Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper.
        Pharmacol Biochem Behav. 2006; 85: 842-849
        • Hauben E.
        • Agranov E.
        • Gothilf A.
        • Nevo U.
        • Cohen A.
        • Smirnov I.
        • et al.
        Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease.
        J Clin Invest. 2001; 108: 591-599
        • Moalem G.
        • Leibowitz-Amit R.
        • Yoles E.
        • Mor F.
        • Cohen I.R.
        • Schwartz M.
        Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy.
        Nat Med. 1999; 5: 49-55
        • Ziv Y.
        • Ron N.
        • Butovsky O.
        • Landa G.
        • Sudai E.
        • Greenberg N.
        • et al.
        Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood.
        Nat Neurosci. 2006; 9: 268-275
        • Cohen H.
        • Ziv Y.
        • Cardon M.
        • Kaplan Z.
        • Matar M.A.
        • Gidron Y.
        • et al.
        Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells.
        J Neurobiol. 2006; 66: 552-563
        • Lewitus G.M.
        • Cohen H.
        • Schwartz M.
        Reducing post-traumatic anxiety by immunization [published online ahead of print June 16].
        Brain Behav Immun. 2008;
        • Kipnis J.
        • Mizrahi T.
        • Hauben E.
        • Shaked I.
        • Shevach E.
        • Schwartz M.
        Neuroprotective autoimmunity: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.
        Proc Natl Acad Sci U S A. 2002; 99: 15620-15625
        • Hauben E.
        • Butovsky O.
        • Nevo U.
        • Yoles E.
        • Moalem G.
        • Agranov E.
        • et al.
        Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.
        J Neurosci. 2000; 20: 6421-6430
        • Gaur A.
        • Boehme S.A.
        • Chalmers D.
        • Crowe P.D.
        • Pahuja A.
        • Ling N.
        • et al.
        Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms.
        J Neuroimmunol. 1997; 74: 149-158
        • Willner P.
        • Towell A.
        • Sampson D.
        • Sophokleous S.
        • Muscat R.
        Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant.
        Psychopharmacology (Berl). 1987; 93: 358-364
        • Willner P.
        Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS.
        Neuropsychobiology. 2005; 52: 90-110
        • Hayward M.D.
        • Pintar J.E.
        • Low M.J.
        Selective reward deficit in mice lacking beta-endorphin and enkephalin.
        J Neurosci. 2002; 22: 8251-8258
      1. Toth E, Gersner R, Wilf-Yarkoni A, Raizel H, Dar D, Richter-Levin G, et al. (in press): Age-dependent effects of chronic stress on brain plasticity and depressive behavior. J Neurochem.

        • Gersner R.
        • Dar D.E.
        • Shabat-Simon M.
        • Zangen A.
        Behavioral analysis during the forced swimming test using a joystick device.
        J Neurosci Methods. 2005; 143: 117-121
        • Baker-Herman T.L.
        • Fuller D.D.
        • Bavis R.W.
        • Zabka A.G.
        • Golder F.J.
        • Doperalski N.J.
        • et al.
        BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia.
        Nat Neurosci. 2004; 7: 48-55
        • Mason D.
        • MacPhee I.
        • Antoni F.
        The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat.
        Immunology. 1990; 70: 1-5
        • Xu H.
        • Chen Z.
        • He J.
        • Haimanot S.
        • Li X.
        • Dyck L.
        • et al.
        Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus.
        Hippocampus. 2006; 6: 551-559
        • Mannie M.D.
        • Paterson P.Y.
        • U'Prichard D.C.
        • Flouret G.
        Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: Delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes.
        Proc Natl Acad Sci U S A. 1985; 82: 5515-5519
        • Czeh B.
        • Michaelis T.
        • Watanabe T.
        • Frahm J.
        • de Biurrun G.
        • van Kampen M.
        • et al.
        Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine.
        Proc Natl Acad Sci U S A. 2001; 98: 12796-12801
        • Xu H.
        • Luo C.
        • Richardson J.S.
        • Li X.M.
        Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine.
        Pharmacogenomics J. 2004; 4: 322-331
        • Santarelli L.
        • Saxe M.
        • Gross C.
        • Surget A.
        • Battaglia F.
        • Dulawa S.
        • et al.
        Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.
        Science. 2003; 301: 805-809